Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients

Major changes are on the horizon for insurance coverage of GLP-1 drugs, a class of medications revolutionizing treatment for both type 2 diabetes and increasingly, weight loss. These impending policy shifts by health insurance providers are poised to significantly alter how patients access these high-demand treatments, potentially reshaping the financial […]